Victory Capital Management
CRMD icon

Victory Capital Management’s CorMedix CRMD Stock Holding History

Victory Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Sell
211,622
-288,181
-58% -$2.28M ﹤0.01% 1686
2026
Q1 		$3.39M Buy
499,803
+184,833
+59% +$1.37M ﹤0.01% 1455
2025
Q4 		$3.66M Buy
314,970
+79,653
+34% +$881K ﹤0.01% 1413
2025
Q3 		$2.74M Buy
+235,317
New +$2.85M ﹤0.01% 1522

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Victory Capital Management's CRMD Position: Q2 2026 in Review

Victory Capital Management reduced its CorMedix (CRMD) stake by 58% in Q2 2026, selling an estimated $2.28M and leaving 211,622 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Victory Capital Management first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.66M in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Victory Capital Management held 211,622 shares of CorMedix worth $1.66M as of Q2 2026.
  • Victory Capital Management sold 288,181 CorMedix shares in Q2 2026, an estimated $2.28M.
  • CorMedix made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1686 holding.
  • Victory Capital Management first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • Victory Capital Management's CorMedix position peaked at $3.66M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.